2026 is the year of obesity pills from Novo Nordisk, Eli Lilly

The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its next chapter. Patients are already getting their hands on the…

What’s next for the weight loss drug market: pills, rivals, insurance

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters The appetite for blockbuster…

Under ED lens: 22 de-addiction centres run by Punjab doctor that ‘sold pills in open market’ | India News

When the Punjab government decided on Tuesday that no private person will be allowed to operate more than five drug de-addiction centres in the state, the move was meant to…

Obesity pills from Eli Lilly, Novo Nordisk near US launch

Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medications: pills. Both companies expect to launch oral obesity drugs in the U.S.…